Clinical trial

Songling Xuemaikang in Hypertension and Insomnia Evaluation（SHINE）

NCT07709442

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2026-06-30

PhaseNA

Study timeline

Study start (estimated)2026-06-30Date precision: day

Registry last updated2026-07-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypertensionunresolved

Interventions

Songling Xuemaikang CapsuleDRUG

Songling Xuemaikang Capsule SimulantDRUG

Sponsors & collaborators

Jing Liulead sponsor

Chengdu Kanghong Pharmaceutical Group Co., Ltd.collaborator

Mapped research locations

BeijingChina1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07709442 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.